Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
45.1M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
16.4K
-
Shares change
-
-27.8M
-
Total reported value, excl. options
-
$78.3K
-
Value change
-
-$125M
-
Number of buys
-
1
-
Number of sells
-
-94
-
Price
-
$6.66
Significant Holders of Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) as of Q3 2025
96 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2025.
Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.4K shares
of 45.1M outstanding shares and own 0.04% of the company stock.
Largest 10 shareholders include Brooklyn Investment Group (16.1K shares), IFP Advisors, Inc (332 shares), CWM, LLC (0 shares), SAPIENT CAPITAL LLC (0 shares), LOS ANGELES CAPITAL MANAGEMENT LLC (0 shares), True Wealth Design, LLC (0 shares), AMALGAMATED BANK (0 shares), NISA INVESTMENT ADVISORS, LLC (0 shares), STRS OHIO (0 shares), and RICE HALL JAMES & ASSOCIATES, LLC (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.